Ozempic-like fat jabs taken by millions linked to 181 cases of killer side effect and 5 deaths, health officials warn
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
FAT jabs have been linked to hundreds of people falling ill with a life-threatening illness and 10 deaths, the UK's drug watchdog has warned.
Brits have reported falling seriously ill with pancreatitis, a condition where the pancreas becomes inflamed, after taking popular weight loss and diabetes drugs.
Sign up for Scottish Sun
newsletter
Sign up
1
Fresh figures from the UK's medicines regulator reveal more than 560 suspected cases of the illness linked to so-called GLP-1 drugs, which include Mounjaro, Wegovy and Ozempic.
At least ten of these cases were fatal, although it's not clear the drugs were directly to blame.
The Medicines and Healthcare products Regulatory Agency (MHRA) says the reports have triggered a new investigation into whether people's genes could make them more vulnerable to side effects.
Since the drugs were approved for use, 181 cases of pancreatitis have been linked to tirzepatide, the active ingredient in Mounjaro, including five deaths.
Another 113 cases have been linked to semaglutide, found in Wegovy and Ozempic, with one fatality. Liraglutide, another weight loss jab, has been tied to 116 suspected cases and one death.
Exenatide has been linked to 101 cases, including three deaths, while dulaglutide and lixisenatide have been associated with 63 cases in total, with no known fatalities.
The MHRA said these are suspected adverse reactions reported by patients, carers or doctors and there is no firm evidence that the jabs directly caused the deaths.
Pancreatitis can also develop in people who don't take these drugs, and is often triggered by gallstones or alcohol.
However, regulators believe there could be a genetic link in some patients, and are now launching a study to investigate.
The Yellow Card Biobank project, set up with Genomics England, is calling on anyone who has been admitted to hospital with pancreatitis while taking a GLP-1 drug to come forward and provide a saliva sample for analysis.
Julia Hartley-Brewer slams government plan for NHS to offer free 'fat jabs' to tackle obesity crisis
Dr Alison Cave, MHRA's chief safety officer, said: "Evidence shows that almost a third of side effects to medicines could be prevented with the introduction of genetic testing, it is predicted that adverse drug reactions could cost the NHS more than £2.2 billion a year in hospital stays alone.
"Information from the Yellow Card Biobank will help us to better predict those most at risk of adverse reactions - enabling patients across the UK to receive the safest medicine for them, based on their genetic makeup.
"To help us help you, we're asking anyone who has been hospitalised with acute pancreatitis while taking a GLP-1 medicine to report this to us via our Yellow Card scheme.
"Even if you don't meet the criteria for this phase of the Biobank study, information about your reaction to a medication is always extremely valuable in helping to improve patient safety."
Pancreatitis is a painful condition that causes severe stomach pain, vomiting and fever.
Acute cases usually clear up with fluids and oxygen in hospital, but around five per cent are fatal or cause lasting damage.
Despite the risks, experts say the drugs are still safe and effective for most patients.
They help control blood sugar, trigger rapid weight loss, and cut the risk of dying from heart disease by around a fifth in people with obesity or type 2 diabetes.
Roughly 1.5million people in the UK are now taking GLP-1 drugs, which have been hailed by some as game-changers in the fight against obesity.
But health officials warn they are not a silver bullet and can come with side effects, most commonly nausea, constipation and diarrhoea.
The MHRA also recently warned that Mounjaro could reduce the effectiveness of the contraceptive pill in some patients.
Professor Matt Brown, chief scientific officer of Genomics England, said: "GLP-1 medicines like Ozempic and Wegovy have been making headlines, but like all medicines there can be a risk of serious side effects.
"We believe there is real potential to minimise these with many adverse reactions having a genetic cause.
"This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription, supporting a shift towards an increasingly prevention-focused healthcare system."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Just 20 posts for newly qualified physiotherapists as 3,000 qualify
There are only 20 job adverts for new physiotherapists entering the NHS workforce, the Chartered Society of Physiotherapy has said. Recruitment freezes appear to be impacting the number of newly qualified physiotherapists trying to get their first NHS job, the CSP said as it called on Government officials to act. This year 3,000 physiotherapy graduates will be finishing their studies and looking for work, the CSP said. NHS Jobs, the health service recruitment website for jobs in England, has just 20 entry level jobs currently on offer, according to CSP analysis. And a poll of 1,800 physiotherapists found 22% said that recruitment of clinical staff is partially paused in their organisation and 11% reported a total pause. Concerns have been raised that UK-trained physiotherapists are seeking work abroad due to 'how hard it is to break into the NHS'. The professional body highlighted how 300,000 people are waiting for musculoskeletal treatment in England alone. Newly qualified physiotherapists can help bring down this waiting list it said, as well as bring down waits for respiratory problems, neurological conditions, and provide post-surgical rehab. The CSP has written to the Department of Health and Social Care, calling for all newly qualified clinicians to be offered an NHS role. Ash James, director of practice and development at the CSP, said: 'It is absurd that with public concern about waiting lists, hundreds of capable and committed graduates are being locked out of the NHS. 'These are professionals who could be seeing up to 15 patients a day for musculoskeletal issues, immediately easing pressure on overstretched services and reducing delays. 'If every graduate had a job, we could begin to cut waiting times now.' Sarah-Jane Ryan, head of practice, learning and development at the School of Education, Sport and Health at the University of Brighton, said: 'This year, most of my students don't have roles lined up which is something we haven't seen for a long time. 'Even first and second year students are now talking about working abroad, because they're hearing how hard it is to break into the NHS. 'We're at risk of losing a whole generation of physios at a time when we urgently need them.' She said these students 'now face the reality of being shut out of the system they were inspired to work in,' adding: 'It's not just a workforce issue – it's a moral one. 'They've made sacrifices and trained for a profession they believe in. 'Placement teams have invested in them, and we know there is a rehab need.'
The Sun
an hour ago
- The Sun
Adults living with chronic pain cite long NHS waiting times among reasons for not getting treated
FOUR in five people living with chronic pain are hiding their condition – held back by stigma, ineffective treatments, and long NHS waiting times, it's been found. Research of 4,000 adults found 54 per cent of those not seeking support blamed long waits for treatment via the health service. 3 Nearly half (45 per cent) are suffering in silence due to scepticism from friends, family, and colleagues. Meanwhile, 40 per cent worry about appearing "weak", and 33 per cent simply don't want to be a burden. Among those who have sought help, 17 per cent reported that traditional treatments aren't working, leaving 41 per cent desperate for alternative pain management options. The research was commissioned for Curaleaf Clinic's Pain Unmasked campaign, which aims to expose the hidden realities of living with chronic pain. Dr Simon Erridge, research director at the medical cannabis clinic, said: 'With traditional treatments failing many, chronic pain patients are left suffering in silence. 'Evidence for medical cannabis is growing, and demand is rising - we have seen a 34 per cent increase in chronic pain patients in the last year - yet many still don't know how to access it. 'Greater awareness and support are needed to ensure patients get the treatment they deserve." It is estimated that close to 28 million people in the UK suffer from chronic pain conditions, and the emotional toll is severe. Everyday activities like sleeping (44 per cent), exercising (40 per cent), socialising (28 per cent), and maintaining relationships (15 per cent) are significantly impacted. And one in five (20 per cent) experience isolation due to their pain. Millions of women live life according to their menstrual cycle, study shows To highlight these hidden struggles, Curaleaf Clinic's campaign brings chronic pain sufferers' experiences to life through art. Collaborating with artist Hayley Wall and three pain sufferers – influencer Mesha Moinirad (CORR), and patients Fran Taylor and Ryan Swanepoel (CORR) – the campaign transforms real pain into physical masks, revealing the emotional burden of masking their condition. Ryan Swanepoel, who has limb girdle muscular dystrophy, a condition which causes weakness and wasting of the muscles around the hips and shoulders, said: "For years, I kept the full extent of my pain hidden - it felt like no one truly understood or knew how to manage it. 'I tried traditional treatments, but they changed who I was and carried risks that made long-term use impossible. 'It wasn't until I discovered medical cannabis that I finally found some form of relief. It's transformed my life, and more people deserve to know this option is out there.' Fran Taylor, who is living with endometriosis, added: 'Endometriosis has controlled my life for 12 years, leaving me waiting endlessly for effective treatment. 3 3 'I was dismissed and misunderstood for so long, feeling completely isolated. Pain shouldn't be suffered in silence - we need to speak up, advocate for ourselves, and get the support we deserve.' Opioids have been one of the most commonly prescribed medications for chronic pain, but only 39 per cent of patients find prescription painkillers such as these most effective. Nearly as many (33 per cent) are now finding alternative therapies like acupuncture, creative therapies (e.g. painting, sculpture) and medical cannabis provide the most relief. However, despite the legalisation of medical cannabis in 2018, awareness and access remain major barriers - with 16 per cent of sufferers unaware it is legal and 18 per cent unsure how to access it. Nearly a third of pain patients (30 per cent) would like to speak to their GP about medical cannabis as a treatment option and 26 per cent would be open to trying it if available on the NHS. Dr Simon Erridge added: 'We provide evidence-backed insights to campaign for greater availability. 'Government support is critical to expanding access for current and future patients. 'Without funding for research and the political will to help medical cannabis patients, progress towards NHS access has stalled. 'No one should be left struggling when potential solutions exist." Ways to reduce pain - approved by the NHS THESE tried-and-tested self-help steps could bring you relief... Get some gently exercise Everyday activities like walking, swimming, gardening and dancing can ease some of the pain directly by blocking pain signals to the brain. Activity can also help lessen pain by stretching stiff and tense muscles, ligaments and joints. Breathe right Concentrating on your breathing when you're in pain can help. When pain is intense, rather than taking shallow, rapid breaths, breathe slowly and deeply. The Pain Toolkit is a booklet packed with simple practical advice on how to live better with long-term pain. The British Pain Society's website also has a number of booklets and patient information leaflets about managing pain. Talking therapies Some people find it useful to get help from a psychologist or hypnotherapist to discover how to deal with their emotions in relation to their pain. Distract yourself Shift your attention on to something else so the pain is not the only thing on your mind. This could involve getting stuck into an activity that you enjoy or find stimulating. Cure sleep problems Many people with long-term pain find it difficult to sleep at night, and sleep deprivation can make pain worse. Go to bed at the same time each evening, and get up at a regular time in the morning. Avoid taking naps in the day, and if sleep problems persist, see a GP. Relax
Rhyl Journal
an hour ago
- Rhyl Journal
Just 20 posts for newly qualified physiotherapists as 3,000 qualify
Recruitment freezes appear to be impacting the number of newly qualified physiotherapists trying to get their first NHS job, the CSP said as it called on Government officials to act. This year 3,000 physiotherapy graduates will be finishing their studies and looking for work, the CSP said. NHS Jobs, the health service recruitment website for jobs in England, has just 20 entry level jobs currently on offer, according to CSP analysis. And a poll of 1,800 physiotherapists found 22% said that recruitment of clinical staff is partially paused in their organisation and 11% reported a total pause. Concerns have been raised that UK-trained physiotherapists are seeking work abroad due to 'how hard it is to break into the NHS'. The professional body highlighted how 300,000 people are waiting for musculoskeletal treatment in England alone. Newly qualified physiotherapists can help bring down this waiting list it said, as well as bring down waits for respiratory problems, neurological conditions, and provide post-surgical rehab. The CSP has written to the Department of Health and Social Care, calling for all newly qualified clinicians to be offered an NHS role. Ash James, director of practice and development at the CSP, said: 'It is absurd that with public concern about waiting lists, hundreds of capable and committed graduates are being locked out of the NHS. 'These are professionals who could be seeing up to 15 patients a day for musculoskeletal issues, immediately easing pressure on overstretched services and reducing delays. 'If every graduate had a job, we could begin to cut waiting times now.' Sarah-Jane Ryan, head of practice, learning and development at the School of Education, Sport and Health at the University of Brighton, said: 'This year, most of my students don't have roles lined up which is something we haven't seen for a long time. 'Even first and second year students are now talking about working abroad, because they're hearing how hard it is to break into the NHS. 'We're at risk of losing a whole generation of physios at a time when we urgently need them.' She said these students 'now face the reality of being shut out of the system they were inspired to work in,' adding: 'It's not just a workforce issue – it's a moral one. 'They've made sacrifices and trained for a profession they believe in. 'Placement teams have invested in them, and we know there is a rehab need.' The Department of Health and Social Care has been approached for comment.
